Faster global financial news!
BioXcel
-
Teva agrees to be stalking-horse bidder for BioXcel's assets for up to $125 million, including $57.5 million upfront, with FDA and auction risks remaining
Teva Pharmaceutical Industries Limited (NYSE:TEVA) has agreed to serve as the initial bidder for substantially all of BioXcel Therapeutics, Inc. (NASDAQ:BTAI)'s assets in a court-supervised Section 36
-
Teva (TEVA) subsidiary agreed to be the stalking-horse bidder for BioXcel Therapeutics' (BTAI) assets in a Chapter 11 auction, offering up to $125M cash plus assumed liabilities.
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Limited, will serve as the initial bidder for substantially all assets of BioXcel Therapeutics, Inc. and certain
-
Teva Pharmaceuticals to acquire BioXcel assets for up to $125m
Teva Pharmaceuticals International has offered to acquire neuroscience assets from BioXcel Therapeutics for a total deal value of up to $125 million. This agreement is part of BioXcel Therapeutics' vo
-
Teva agrees to be stalking-horse bidder for BioXcel's assets for up to $125 million, including $57.5 million upfront, with FDA and auction risks remaining
Teva Pharmaceutical Industries Limited (NYSE:TEVA) has agreed to serve as the initial bidder for substantially all of BioXcel Therapeutics, Inc. (NASDAQ:BTAI)'s assets in a court-supervised Section 36
-
Teva (TEVA) subsidiary agreed to be the stalking-horse bidder for BioXcel Therapeutics' (BTAI) assets in a Chapter 11 auction, offering up to $125M cash plus assumed liabilities.
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Limited, will serve as the initial bidder for substantially all assets of BioXcel Therapeutics, Inc. and certain
-
Teva Pharmaceuticals to acquire BioXcel assets for up to $125m
Teva Pharmaceuticals International has offered to acquire neuroscience assets from BioXcel Therapeutics for a total deal value of up to $125 million. This agreement is part of BioXcel Therapeutics' vo
- No data
BioXcel
24H Trending
-
1
CoreWeave's default probability exceeds 60%, but NVIDIA CEO Jensen Huang states its financing costs are decreasing and NVIDIA is not required to backstop it.
-
2
UKMTO Warns of "Severe" Threat to Shipping in Strait of Hormuz, Attacks "Highly Likely"
-
3
CoreWeave Credit Default Swaps Hit Distressed Levels Amid Investor Concerns Over AI Debt
-
4
AWS, Anthropic, OpenAI and Google are racing to deploy specialized AI engineers to help companies realize returns on their AI investments
-
5
MSCI adopts new index exclusion rules; Strategy and Metaplanet may face removal, SharpLink placed on review list.
-
6
Fed's Hammack: Financial conditions do not appear restrictive right now
-
7
US embassy warns of potential attacks on Saudi airports, restricts staff travel and urges citizens to take extreme caution
-
8
MSCI Launches Consultation to Reclassify Indonesia Equity Indexes from Emerging to Standalone Market Status
-
9
Porsche CEO Michael Leiters discusses new Mission S supercar, China market, and future of EVs
-
10
Jensen Huang Responds to AI Compute Investment Anxiety: Backs CoreWeave, Says Market Misreads Compute Demand
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
